Please try another search
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Name | Age | Since | Title |
---|---|---|---|
Brian Ward | - | 2007 | Founder, CEO, MD & Executive Director |
John Richard Pinion | 55 | 2015 | Independent Non-Executive Director |
James Neil McLean | - | 2011 | Independent Non-Executive Chairperson |
Philip McCaw | - | 2008 | Non-Executive Director |
John Flower Diddams | 74 | 2019 | Independent Non-Executive Director |
Catherine Mohr | 55 | 2022 | Independent Non-Executive Director |
Darla Hutton | - | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review